DV-230

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDV-230
Drug Alias NameTLR9-adjuvanted nanoparticle vaccine (Dynavax Technologies)DV-230
ClassificationBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynavax Technologies Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A